MedinCell announces that mdc-CWM progresses as planned
27 September 2019
Our news
Bringing you the latest!
Corporate
The MedinCell General Meeting votes to include the “Raison d’être” of the Company in its articles of association
10 September 2019
MedinCell receives a new grant to develop a best-in-class long-acting injectable product for HIV PrEP
5 September 2019
LAI antipsychotic using MedinCell’s technology receives FDA IND clearance to initiate clinical activities
26 August 2019
Third long-acting injectable antipsychotic using MedinCell’s technology enters preclinical development
9 July 2019
MedinCell wins the #LetsgoFrance 2019 trophy in the category “France, a model of sustainable economy” (in French)
5 April 2019
MedinCell demonstrates in vivo the efficacy of the first injectable combining surgical anesthesia and 3 days opioid free postoperative pain management
11 March 2019
MedinCell receives 2nd part of the grant from the Bill & Melinda Gates Foundation
24 January 2019